What is Trulicity?
Trulicity is a prescription medication used to treat type 2 diabetes. It contains the active ingredient dulaglutide, which is a GLP-1 receptor agonist that helps regulate blood sugar levels by increasing insulin secretion and decreasing glucagon secretion. Trulicity is typically administered once a week via subcutaneous injection using a pre-filled pen.
While Trulicity can be effective in helping to manage blood sugar levels, it does carry some risks and potential side effects. These can include gastrointestinal issues, such as nausea and diarrhea, as well as more serious side effects, such as pancreatitis and thyroid cancer.
Trulicity is available only by prescription and can be costly, depending on insurance coverage. Patients should talk to their healthcare providers about the risks and benefits of Trulicity and whether it is right for them. They should also carefully follow the medication instructions, including the dosage and injection technique, to ensure the medication is properly administered and to reduce the risk of side effects.
Frequently Asked Questions about trulicity
NARRATOR: Trulicity is a once-weekly injectable prescription medicine for adults and children 10 years of age and older with type 2 diabetes used to improve blood sugar along with diet and exercise and proven to reduce the risk of major cardiovascular events in adults with type 2 diabetes with known heart disease and ...
Trulicity is the trade name of dulaglutide, a type 2 diabetes medication made by Eli Lilly. Trulicity is part of a class of drugs called GLP-1 receptor agonists Other GLP-1 receptor agonists include: Bydureon (Exenatide)
Trulicity may also be given to reduce the risk of future cardiovascular events, such as a heart attack or stroke, in people with type 2 diabetes who also have heart disease. Trulicity is effective at reducing blood glucose levels and it also reduces body weight.
Each 0.5 mL of TRULICITY solution contains 0.75 mg or 1.5 mg of dulaglutide. Each single-dose pen contains 0.5 mL of solution and the following excipients: citric acid anhydrous (0.07 mg), mannitol (23.2 mg), polysorbate 80 (0.10 mg), trisodium citrate dihydrate (1.37 mg), in water for injection.
SAFETY SUMMARY WITH WARNINGS
Trulicity may cause tumors in the thyroid, including thyroid cancer. Watch for possible symptoms, such as a lump or swelling in the neck, trouble swallowing, hoarseness, or shortness of breath. If you have any of these symptoms, tell your healthcare provider.
Trulicity is a non-insulin option that helps your body release the insulin it's already making. Trulicity is not a weight loss drug. In studies with other diabetes medications, weight change in adults ranged from +0.4 lbs (0.75 mg) to −10.1 lbs (4.5 mg). Individual results may vary.
Trulicity is used in adults with type 2 diabetes to reduce the risk of major cardiovascular events (problems having to do with the heart and blood vessels) such as death, heart attack, or stroke in people who have heart disease or multiple cardiovascular risk factors.
Trulicity is a once-weekly injectable prescription medicine to improve blood sugar (glucose) in adults and children 10 years of age and older with type 2 diabetes mellitus. It should be used along with diet and exercise. It is not known if TRULICITY can be used in people who have had pancreatitis.
But some cases of acute kidney damage have also been reported. Most commonly, kidney damage appears to happen in people experiencing severe nausea, vomiting, and diarrhea from Trulicity. These side effects can result in dehydration, which can lead to kidney damage or worsen existing kidney problems.
Trulicity is not a weight loss drug, but some people may lose weight. People lost, on average, two to six pounds while taking Trulicity. However, 15 to 30% gained weight. One of the ways Trulicity works is by helping to make you feel full after a meal.
Warnings: Trulicity may cause tumors in the thyroid, including thyroid cancer. Watch for possible symptoms, such as a lump or swelling in the neck, trouble swallowing, hoarseness, or shortness of breath.
Studies have shown that Trulicity can lead to more weight loss than metformin alone. It's also been shown to cause more weight loss than sitagliptin (Januvia), another popular diabetes medication, when added to metformin. The amount of weight you can lose with Trulicity may depend on the dose.
Trulicity should not be used by people with type 1 diabetes, people with diabetic ketoacidosis, or people with a history of severe stomach or intestinal problems. It has not been studied in children under 18 years of age. Trulicity has a Boxed Warning about potential thyroid tumors, including cancer.
Warnings: Trulicity may cause tumors in the thyroid, including thyroid cancer. Watch for possible symptoms, such as a lump or swelling in the neck, trouble swallowing, hoarseness, or shortness of breath. If you have any of these symptoms, tell your healthcare provider.
INDIANAPOLIS , Feb. 21, 2020 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved Trulicity® (dulaglutide) for the reduction of major adverse cardiovascular events (MACE) in adults with type 2 diabetes who have established cardiovascular (CV) disease or multiple cardiovascular risk factors.
Studies have shown that Trulicity can lead to more weight loss than metformin alone. It's also been shown to cause more weight loss than sitagliptin (Januvia), another popular diabetes medication, when added to metformin. The amount of weight you can lose with Trulicity may depend on the dose.
